Abstract
It is one of the “Rights of the Child” not to have to endure pain [1, 2]. In the past there was little knowledge or understanding of pain in children [3]. Many of us were taught that babies do not feel pain. Minor operations such as circumcision were often performed on neonates with no analgesia. We now know this to be a cruel misconception and in fact neonates have an enhanced, more global response to pain. Sensitization of the nervous system by trauma at such an early age can lead to different pain behavior in later life [4]. This global response in neonates is due in part to the poor hyalinization of nerves at this early stage of life, and also to the inability to localize pain until the brain develops a proper body image in the first few months of life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Southall DP, et al. The Child-Friendly Healthcare Initiative (CFHI): healthcare provision in accordance with the UN Convention on the Rights of the Child. Pediatrics. 2000;106(5):1054–64.
http://www.childfriendlyhealthcare.org/publications/pediatrics.htm.
Bonica JJ. Evolution and current status of pain programs. J Pain Symptom Manage. 1990;5(6):368–74 (review).
Taddio A, Katz J. The effects of early pain experience in neonates on pain responses in infancy and childhood. Paediatr Drugs. 2005;7(4):245–57 (review).
Franck LS, Greenberg CS, Stevens B. Pain assessment in infants and children. In: Yaster M, editor. The pediatric clinics of North America. Philadelphia: Lippincott; 2000. p. 487–512.
Bonica JJ. The management of pain, vol. 1. 2nd ed. Pennsylvania: Lea and Febiger; 1990.
Fitzgerald M, Howard RF. The neurobiologic basis of pediatric pain. In: Schecter NL, Berde CB, Yaster M, editors. Pain in infants, children and adolescents. 2nd ed. Philadelphia: Lippincott; 2003. p. 19–42.
Hu P, McLachlan EM. Long-term changes in the distribution of galanin in dorsal root ganglia after sciatic or spinal nerve transection in rats. Neuroscience. 2001;103(4):1059–71.
Bago M, Dean C. Sympathoinhibition from ventrolateral periaqueductal gray mediated by 5-HT(1A) receptors in the RVLM. Am J Physiol Regul Integr Comp Physiol. 2001;280(4):R976–84.
Holmberg K, Shi TJ, Albers KM, Davis BM, Hokfelt T. Effect of peripheral nerve lesion and lumbar sympathectomy on peptide regulation in dorsal root ganglia in the NGF-overexpressing mouse. Exp Neurol. 2001;167(2):290–303.
Scislo TJ, Kitchen AM, Augustyniak RA, O’Leary DS. Differential patterns of sympathetic responses to selective stimulation of nucleus tractus solitarius purinergic receptor subtypes. Clin Exp Pharmacol Physiol. 2001;28(1–2):120–4 (review).
Chabal C. Membrane stabilizing agents and experimental neuromas. In: Fields HL, Liebeskind JC, editors. Pharmacological approaches to the treatment of chronic pain: new concepts and critical issues, Progress in pain research and management, vol. 1. Seattle: IASP Press; 1994. p. 205–10.
Halligan PW, Zeman A, Berger A. Phantoms in the brain. Question the assumption that the adult brain is “hard wired.”. BMJ. 1999;319(7210):587–8.
Centre for Synaptic Plasticity. http://www.bris.ac.uk/Depts/Synaptic/info/glutamate.html.
Dev KK, Henley JM. The regulation of AMPA receptor-binding sites. Mol Neurobiol. 1998;17(1–3):33–58.
Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG. Glutamate-mediated astrocyte-neuron signalling. Nature. 1994;369(6483):707–8.
Dendorfer A, Wolfrum S, Dominiak P. Pharmacology and cardiovascular implications of the kinin-kallikrein system. Jpn J Pharmacol. 1999;79:403–26.
Skidgel RA, Alhenc-Gelas F, Campbell WB. Relation of cardiovascular signaling by kinins and products of similar converting enzyme systems; prologue: kinins and related systems. New life for old discoveries. Am J Physiol Heart Circ Physiol. 2003;284:H1886–91.
Dendorfer A, Wolfrum S, Wagemann M, Qadri F, Dominiak P. Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats. Am J Physiol Heart Circ Physiol. 2001;280:H2182–8.
Kuoppala A, Lindstedt KA, Saarinen J, Kovanen PT, Kokkonen JO. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma. Am J Physiol Heart Circ Physiol. 2000;278(4):H1069–74.
Kozlowska M, Smolenski RT, Makarewicz W, Hoffmann C, Jastorff B, Swierczynski J. ATP depletion, purine riboside triphosphate accumulation and rat thymocyte death induced by purine riboside. Toxicol Lett. 1999;104(3):171–81.
Kondo M, Yamaoka T, Honda S, et al. The rate of cell growth is regulated by purine biosynthesis via ATP production and G1 to S phase transition 1. J Biochem. 2000;128(1):57–64.
Yegutkin GG, Samburski SS, Jalkanen S. Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions. FASEB J. 2003;17(10):1328–30. Epub 2003 May 20.
Schurmann M, Gradl G, Wizgal I, Tutic M, Moser C, Azad S, Beyer A. Clinical and physiologic evaluation of stellate ganglion blockade for complex regional pain syndrome type I. Clin J Pain. 2001;17(1):94–100.
Cleary AG, Sills JA, Davidson JE, Cohen AM. Reflex sympathetic dystrophy. Rheumatology (Oxford). 2001;40(5):590–1.
Ceballos A, Cabezudo L, Bovaira M, Fenollosa P, Moro B. Spinal cord stimulation: a possible therapeutic alternative for chronic mesenteric ischaemia. Pain. 2000;87(1):99–101.
McCleane G. Pharmacological strategies in relieving neuropathic pain. Expert Opin Pharmacother. 2004;5(6):1299–312.
Manning DC. New and emerging pharmacological targets for neuropathic pain. Curr Pain Headache Rep. 2004;8(3):192–8.
Cousins MJ, Mather LE. Intrathecal and extradural administration of opioids. Anesthesiology. 1984;61:276–310.
Chaney MA. Side effects of intrathecal and extradural opiates. Can J Anaesth. 1995;42:891–903.
Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci. 2004;101(26):9861–6.
Maihofner C, Handwerker HO, Neundorfer B, Birklein F. Patterns of cortical reorganisation in complex regional pain syndrome. Neurology. 2003;61(12):1707–15.
Buskila D, Neumann L, Press J. Genetic factors in neuromuscular pain. CNS Spectr. 2005;10(4):281–4.
Finegold AA, Mannes AJ, Iadarola MJ. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther. 1999;10(7):1251–7.
Kaye P. Pocket book of symptom control. Northampton: EPL Publications; 1994. p. 72.
Smith O. Pain-killer genes. Science. 1999;284(5420):1634.
Currie JM. Management of chronic pain in children. Arch Dis Child. 2006;91:111–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Currie, J. (2016). Pain Management. In: Carachi, R., Grosfeld, J. (eds) The Surgery of Childhood Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48590-3_39
Download citation
DOI: https://doi.org/10.1007/978-3-662-48590-3_39
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48588-0
Online ISBN: 978-3-662-48590-3
eBook Packages: MedicineMedicine (R0)